Seguir
Fady Ibrahim
Fady Ibrahim
Dirección de correo verificada de Sanofi.com
Título
Citado por
Citado por
Año
Assessment of novel oral lipid-based formulations of amphotericin B using an in vitro lipolysis model
F Ibrahim, P Gershkovich, O Sivak, EK Wasan, KM Wasan
European journal of pharmaceutical sciences 46 (5), 323-328, 2012
342012
Novel High-Drug-Loaded Amorphous Dispersion Tablets of Posaconazole; In Vivo and In Vitro Assessment
DM Mudie, AM Stewart, N Biswas, TJ Brodeur, KB Shepard, A Smith, ...
Molecular Pharmaceutics 17 (12), 4463-4472, 2020
292020
In vivo study and thermodynamic investigation of two lanthanum complexes, La (dpp) 3 and La (XT), for the treatment of bone resorption disorders
JF Cawthray, DM Weekes, O Sivak, AL Creagh, F Ibrahim, M Iafrate, ...
Chemical Science 6 (11), 6439-6447, 2015
262015
The use of the United States FDA programs as a strategy to advance the development of drug products for neglected tropical diseases
K Sachs-Barrable, J Conway, P Gershkovich, F Ibrahim, KM Wasan
Drug development and industrial pharmacy 40 (11), 1429-1434, 2014
262014
Pharmacokinetics and tissue distribution of amphotericin B following oral administration of three lipid-based formulations to rats
F Ibrahim, P Gershkovich, O Sivak, EK Wasan, KM Wasan
Drug Development and Industrial Pharmacy 39 (9), 1277-1283, 2013
202013
Effect of variations in treatment regimen and liver cirrhosis on exposure to benzodiazepines during treatment of alcohol withdrawal syndrome
P Gershkovich, KM Wasan, C Ribeyre, F Ibrahim, JH McNeill
Drugs in context 4, 2015
192015
A simple and sensitive method for determination of vitamins D3 and K1 in rat plasma: application for an in vivo pharmacokinetic study
P Gershkovich, F Ibrahim, O Sivak, JW Darlington, KM Wasan
Drug Development and Industrial Pharmacy 40 (3), 338-344, 2014
182014
Efficacy and toxicity of a tropically stable lipid-based formulation of amphotericin B (iCo-010) in a rat model of invasive candidiasis
F Ibrahim, P Gershkovich, O Sivak, EK Wasan, K Bartlett, KM Wasan
International journal of pharmaceutics 436 (1-2), 318-323, 2012
182012
Efficacy of an oral and tropically stable lipid-based formulation of Amphotericin B (iCo-010) in an experimental mouse model of systemic candidiasis
F Ibrahim, O Sivak, EK Wasan, K Bartlett, KM Wasan
Lipids in Health and Disease 12, 1-5, 2013
162013
Hormonal sex reversal in Oreochromis niloticus by oral administration of diethylstilbestrol
NT Hamdoon, F Ibrahim, AM Kelany, FE Hanan, AE Zayed
Life Science Journal 10 (2), 2123-2128, 2013
122013
Impact of co-administration of protonated nanostructured aluminum silicate (cholesterol absorption inhibitor) on the absorption of lipid soluble vitamins D3 and K1: An …
F Ibrahim, O Sivak, C Wong, P Hopkins, A Midha, J Gordon, ...
European Journal of Pharmaceutical Sciences 49 (2), 125-132, 2013
72013
UPLC–MS/MS assay of 21-aminosteroid (lazaroid U74389G) for application in pharmacokinetic study
P Gadgil, F Ibrahim, DSL Chow
Journal of Pharmaceutical and Biomedical Analysis 122, 90-97, 2016
52016
A Combined In-Vitro and GastroPlus® Modeling to Study the Effect of Intestinal Precipitation on Cinnarizine Plasma Profile in a Fasted State
SS Kesharwani, F Ibrahim
AAPS PharmSciTech 24 (5), 121, 2023
32023
An enabling formulation of a weakly basic compound guided by Physiologically Based Biopharmaceutics Modeling (PBBM)
F Ibrahim
Journal of Pharmaceutical Sciences 111 (9), 2490-2495, 2022
32022
The Use of Global Sensitivity Analysis to Assess the Oral Absorption of Weakly Basic Compounds: A Case Example of Dipyridamole
SS Kesharwani, G Louit, F Ibrahim
Pharmaceutical Research, 1-14, 2024
2024
InstMC Membership Elections and Transfers
SF Wong, KAR Hasan, SA Kriescher, S Wales, AM Withers, AA Abdulkadir, ...
Measurement and Control 49 (2), 53, 2016
2016
A Systematic Study into the Interaction of Lanthanides with Hydroxyapatite
J Cawthray, D Weekes, C Orvig, L Creagh, Y Makhdoom, C Haynes, ...
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY 19, S692-S692, 2014
2014
EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY
C Aaberg-Jessen, L Fogh, B Halle, V Jensen, N Brünner, B Kristensen, ...
Neuro-oncology 15 (Suppl 3), iii37-iii61, 2013
2013
Chemoembolization with super absorbent polymer microspheres (SAP-MS) loaded with doxorubicin (D) using escalating doses and adverse events (AE) in resectable hepatocellular …
RDA Peixoto, HJ Lim, F Ibrahim, E Wasan, JA Ford, DM Liu
Journal of Clinical Oncology 31 (15_suppl), e15084-e15084, 2013
2013
Effects of Lazaroid U-74389G Liposomes in a Glioblastoma Mouse Model (P02. 159)
F Ibrahim, P New, K Cui, H Zhao, D Chow, S Wong
Neurology 80 (7 Supplement), P02. 159-P02. 159, 2013
2013
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20